Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day

[GlobeNewswire] – CHARLOTTE, N.C. — Chelsea Therapeutics International, Ltd. , which recently received Food and Drug Administration (FDA) accelerated approval of NORTHERATM (droxidopa) for the treatment of symptomatic … more

View todays social media effects on CHTP

View the latest stocks trending across Twitter. Click to view dashboard

See who Chelsea is hiring next, click here to view